Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?

K. Kuus-Reichel, L. S. Grauer, L. M. Karavodin, C. Knott, M. Krusemeier, N. E. Kay

Research output: Contribution to journalReview article

153 Scopus citations
Original languageEnglish (US)
Pages (from-to)365-372
Number of pages8
JournalClinical and Diagnostic Laboratory Immunology
Volume1
Issue number4
DOIs
StatePublished - Jan 1 1994

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Clinical Biochemistry
  • Microbiology (medical)

Cite this